Schonfeld Strategic Advisors LLC raised its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 134.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 121,935 shares of the company's stock after purchasing an additional 70,020 shares during the period. Schonfeld Strategic Advisors LLC owned 0.05% of Cardinal Health worth $14,421,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of the stock. Geode Capital Management LLC grew its holdings in Cardinal Health by 1.9% in the 4th quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company's stock valued at $691,145,000 after buying an additional 109,273 shares in the last quarter. Invesco Ltd. increased its position in Cardinal Health by 4.6% during the fourth quarter. Invesco Ltd. now owns 3,182,514 shares of the company's stock worth $376,396,000 after acquiring an additional 140,368 shares during the period. Marshall Wace LLP increased its position in Cardinal Health by 154.6% during the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock worth $372,756,000 after acquiring an additional 1,913,892 shares during the period. Northern Trust Corp raised its stake in Cardinal Health by 16.2% in the 4th quarter. Northern Trust Corp now owns 3,037,849 shares of the company's stock worth $359,286,000 after purchasing an additional 422,755 shares in the last quarter. Finally, Amundi boosted its holdings in Cardinal Health by 5.5% in the 4th quarter. Amundi now owns 2,116,291 shares of the company's stock valued at $259,309,000 after purchasing an additional 110,605 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.
Cardinal Health Stock Performance
Shares of NYSE:CAH traded up $4.06 during mid-day trading on Friday, reaching $149.59. 3,365,880 shares of the company's stock were exchanged, compared to its average volume of 2,195,707. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $150.12. The firm has a market capitalization of $36.14 billion, a price-to-earnings ratio of 27.91, a PEG ratio of 1.49 and a beta of 0.61. The business's fifty day moving average price is $132.38 and its 200-day moving average price is $124.98.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. During the same quarter in the previous year, the company posted $2.08 EPS. The business's revenue was up .0% on a year-over-year basis. Analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st were paid a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date was Tuesday, April 1st. Cardinal Health's dividend payout ratio is presently 37.69%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on CAH shares. JPMorgan Chase & Co. lifted their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Mizuho upped their target price on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday, March 31st. Robert W. Baird raised their price target on Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a research report on Friday. Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective for the company in a research report on Tuesday, January 7th. Finally, Wells Fargo & Company raised their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, Cardinal Health has an average rating of "Moderate Buy" and a consensus price target of $144.71.
Check Out Our Latest Stock Analysis on CAH
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
